{
      "Rank": 433,
      "Acronym": [],
      "AgreementOtherDetails": [],
      "AgreementPISponsorEmployee": [],
      "AgreementRestrictionType": [],
      "AgreementRestrictiveAgreement": [],
      "ArmGroupDescription": [
            "Three doses of Neural progenitor cell (4*10^6) intrathecally at 48-72h, 5d and 10d after birth.+routine therapy",
            "Three doses of concentrated paracrine factors of human mesenchymal stem cell \uff080.5ml\uff09 intrathecally at 12h,24h,48h after birth.+routine therapy",
            "Three doses of concentrated paracrine factors 0.5ml intrathecally at 12h,24h,48h after birth.And three doses of neural progenitor cell (4*10^6) intrathecally at 48-72h, 5d and 10d after birth.+routine therapy",
            "neonates only receive routine therapy"
      ],
      "ArmGroupInterventionName": [
            "Biological: neural progenitor cell",
            "Biological: Paracrine factors",
            "Biological: progenitor cell and paracrine factors"
      ],
      "ArmGroupLabel": [
            "Neural progenitor cell",
            "Paracrine factors",
            "Progenitor cell and paracrine factors",
            "Routine therapy"
      ],
      "ArmGroupType": [
            "Experimental",
            "Experimental",
            "Experimental",
            "No Intervention"
      ],
      "AvailIPDComment": [],
      "AvailIPDId": [],
      "AvailIPDType": [],
      "AvailIPDURL": [],
      "BaselineCategoryTitle": [],
      "BaselineClassDenomCountGroupId": [],
      "NCTId": [
            "NCT02854579"
      ],
      "BaselineClassDenomCountValue": [],
      "BaselineClassDenomUnits": [],
      "BaselineClassTitle": [],
      "BaselineDenomCountGroupId": [],
      "BaselineDenomCountValue": [],
      "BaselineDenomUnits": [],
      "BaselineGroupDescription": [],
      "BaselineGroupId": [],
      "BaselineGroupTitle": [],
      "BaselineMeasureCalculatePct": [],
      "BaselineMeasureDenomCountGroupId": [],
      "BaselineMeasureDenomCountValue": [],
      "BaselineMeasureDenomUnits": [],
      "BaselineMeasureDenomUnitsSelected": [],
      "BaselineMeasureDescription": [],
      "BaselineMeasureDispersionType": [],
      "BaselineMeasureParamType": [],
      "BaselineMeasurePopulationDescription": [],
      "BaselineMeasureTitle": [],
      "BaselineMeasureUnitOfMeasure": [],
      "BaselineMeasurementComment": [],
      "BaselineMeasurementGroupId": [],
      "BaselineMeasurementLowerLimit": [],
      "BaselineMeasurementSpread": [],
      "BaselineMeasurementUpperLimit": [],
      "BaselineMeasurementValue": [],
      "BaselinePopulationDescription": [],
      "BaselineTypeUnitsAnalyzed": [],
      "BioSpecDescription": [],
      "BioSpecRetention": [],
      "BriefSummary": [
            "The purpose of this study is to investigate the efficacy and safety of allogenic neural progenitor cell and paracrine factors of human mesenchymal stem cells for patients with moderate/severe Hypoxic-Ischemic Encephalopathy"
      ],
      "BriefTitle": [
            "Neural Progenitor Cell and Paracrine Factors to Treat Hypoxic Ischemic Encephalopathy"
      ],
      "CentralContactEMail": [
            "hjzyyerke@163.com",
            "hjzyynicu@163.com"
      ],
      "CentralContactName": [
            "Zuo Luan, MD",
            "Weipeng Liu, MD"
      ],
      "CentralContactPhone": [
            "18600317210",
            "13581797015"
      ],
      "CentralContactPhoneExt": [],
      "CentralContactRole": [
            "Contact",
            "Contact"
      ],
      "CollaboratorClass": [
            "OTHER",
            "OTHER",
            "OTHER_GOV",
            "OTHER",
            "UNKNOWN"
      ],
      "CollaboratorName": [
            "Bethune International Peace Hospital",
            "Daping Hospital and the Research Institute of Surgery of the Third Military Medical University",
            "Hunan Children's Hospital",
            "Shangluo Central Hospital",
            "252 Military Hospital"
      ],
      "CompletionDate": [
            "December 2017"
      ],
      "CompletionDateType": [
            "Anticipated"
      ],
      "Condition": [
            "Hypoxic-Ischemic Encephalopathy"
      ],
      "ConditionAncestorId": [
            "D000010335",
            "D000002493",
            "D000009422",
            "D000012818",
            "D000002561",
            "D000014652",
            "D000002318",
            "D000002534"
      ],
      "ConditionAncestorTerm": [
            "Pathologic Processes",
            "Central Nervous System Diseases",
            "Nervous System Diseases",
            "Signs and Symptoms, Respiratory",
            "Cerebrovascular Disorders",
            "Vascular Diseases",
            "Cardiovascular Diseases",
            "Hypoxia, Brain"
      ],
      "ConditionBrowseBranchAbbrev": [
            "BC23",
            "All",
            "BC10",
            "BC14"
      ],
      "ConditionBrowseBranchName": [
            "Symptoms and General Pathology",
            "All Conditions",
            "Nervous System Diseases",
            "Heart and Blood Diseases"
      ],
      "ConditionBrowseLeafAsFound": [
            "Ischemic",
            "Ischemic Encephalopathy",
            "Hypoxic",
            "Encephalopathy",
            "Hypoxic Ischemic Encephalopathy"
      ],
      "ConditionBrowseLeafId": [
            "M9695",
            "M4946",
            "M3337",
            "M4356",
            "M21813",
            "M4894",
            "M14775",
            "M4962",
            "M16552",
            "M4935"
      ],
      "ConditionBrowseLeafName": [
            "Ischemia",
            "Brain Ischemia",
            "Hypoxia",
            "Brain Diseases",
            "Hypoxia-Ischemia, Brain",
            "Central Nervous System Diseases",
            "Signs and Symptoms, Respiratory",
            "Cerebrovascular Disorders",
            "Vascular Diseases",
            "Hypoxia, Brain"
      ],
      "ConditionBrowseLeafRelevance": [
            "high",
            "high",
            "high",
            "high",
            "high",
            "low",
            "low",
            "low",
            "low",
            "low"
      ],
      "ConditionMeshId": [
            "D000001927",
            "D000002545",
            "D000020925",
            "D000007511",
            "D000000860"
      ],
      "ConditionMeshTerm": [
            "Brain Diseases",
            "Brain Ischemia",
            "Hypoxia-Ischemia, Brain",
            "Ischemia",
            "Hypoxia"
      ],
      "DelayedPosting": [],
      "DesignAllocation": [
            "Randomized"
      ],
      "DesignInterventionModel": [
            "Parallel Assignment"
      ],
      "DesignInterventionModelDescription": [],
      "DesignMasking": [
            "None (Open Label)"
      ],
      "DesignMaskingDescription": [],
      "DesignObservationalModel": [],
      "DesignPrimaryPurpose": [
            "Treatment"
      ],
      "DesignTimePerspective": [],
      "DesignWhoMasked": [],
      "DetailedDescription": [
            "Neonates diagnosed moderate/severe Hypoxic-Ischemic Encephalopathy after birth will receive routine therapy and be randomized to four arms for allogenic neural progenitor cells transplantation\uff0cparacrine factors of human mesenchymal stem cells intrathecal injection\uff0ccombination of cell and factor or only routine therapy. Patients will be followed for neurodevelopmental outcome at 12 and 18 months in Pediatrics of Navy General Hospital. Magnetic Resonance Imaging, electroencephalogram, Bailey scores, Peabody development measure scale and Gross motor function measure assessment will be obtained in the following research.Results will be analyzed and described in study reports."
      ],
      "DispFirstPostDate": [],
      "DispFirstPostDateType": [],
      "DispFirstSubmitDate": [],
      "DispFirstSubmitQCDate": [],
      "EligibilityCriteria": [
            "Inclusion Criteria:\n\ngestational age \u2265 34weeks, body weight \u2265 2kg.\n1 minute apgar score \u22643, and 5 minutes apgar score \u22645, OR umbilical arterial blood gas potential of hydrogen<7.0, OR 30 minutes base excess\u2264-12 mmol/L, OR need for ventilation 5 minutes after birth.\nAll infants must have signs of encephalopathy (such as convulsion, coma, dystonia, abnormal primitive reflex and irregular respiration) within 6 hours of age or continued abnormal EEG for more than 24h.\n\nExclusion Criteria:\n\nDoes not meet the inclusion criteria\nSuffer from other serious organic disease or congenital, hereditary metabolic diseases\nIntracranial active infection, or neuromuscular damage outside central nervous system\npotential of hydrogen / electrolyte disorders without improvement or stability\nCoagulation disorders associated with bleeding tendency\nImmune function is not perfect\nPatients or his guardian refuse consent.\nPatients or his guardian don't accept the follow-up schedule."
      ],
      "EnrollmentCount": [
            "120"
      ],
      "EnrollmentType": [
            "Anticipated"
      ],
      "EventGroupDeathsNumAffected": [],
      "EventGroupDeathsNumAtRisk": [],
      "EventGroupDescription": [],
      "EventGroupId": [],
      "EventGroupOtherNumAffected": [],
      "EventGroupOtherNumAtRisk": [],
      "EventGroupSeriousNumAffected": [],
      "EventGroupSeriousNumAtRisk": [],
      "EventGroupTitle": [],
      "EventsDescription": [],
      "EventsFrequencyThreshold": [],
      "EventsTimeFrame": [],
      "ExpAccTypeIndividual": [],
      "ExpAccTypeIntermediate": [],
      "ExpAccTypeTreatment": [],
      "ExpandedAccessNCTId": [],
      "ExpandedAccessStatusForNCTId": [],
      "FDAAA801Violation": [],
      "FlowAchievementComment": [],
      "FlowAchievementGroupId": [],
      "FlowAchievementNumSubjects": [],
      "FlowAchievementNumUnits": [],
      "FlowDropWithdrawComment": [],
      "FlowDropWithdrawType": [],
      "FlowGroupDescription": [],
      "FlowGroupId": [],
      "FlowGroupTitle": [],
      "FlowMilestoneComment": [],
      "FlowMilestoneType": [],
      "FlowPeriodTitle": [],
      "FlowPreAssignmentDetails": [],
      "FlowReasonComment": [],
      "FlowReasonGroupId": [],
      "FlowReasonNumSubjects": [],
      "FlowReasonNumUnits": [],
      "FlowRecruitmentDetails": [],
      "FlowTypeUnitsAnalyzed": [],
      "Gender": [
            "All"
      ],
      "GenderBased": [],
      "GenderDescription": [],
      "HasExpandedAccess": [
            "No"
      ],
      "HealthyVolunteers": [
            "No"
      ],
      "IPDSharing": [
            "No"
      ],
      "IPDSharingAccessCriteria": [],
      "IPDSharingDescription": [],
      "IPDSharingInfoType": [],
      "IPDSharingTimeFrame": [],
      "IPDSharingURL": [],
      "InterventionAncestorId": [],
      "InterventionAncestorTerm": [],
      "InterventionArmGroupLabel": [
            "Neural progenitor cell",
            "Paracrine factors",
            "Progenitor cell and paracrine factors"
      ],
      "InterventionBrowseBranchAbbrev": [],
      "InterventionBrowseBranchName": [],
      "InterventionBrowseLeafAsFound": [],
      "InterventionBrowseLeafId": [],
      "InterventionBrowseLeafName": [],
      "InterventionBrowseLeafRelevance": [],
      "InterventionDescription": [
            "Neural progenitor cells are derived from the same aborted human fetal forebrain.",
            "The factors obtained from cultured human mesenchymal stem cells were concentrated 50 times",
            "Neural progenitor cells will be received after paracrine factors therapy"
      ],
      "InterventionMeshId": [],
      "InterventionMeshTerm": [],
      "InterventionName": [
            "neural progenitor cell",
            "Paracrine factors",
            "progenitor cell and paracrine factors"
      ],
      "InterventionOtherName": [
            "paracrine factor of human mesenchymal stem cells"
      ],
      "InterventionType": [
            "Biological",
            "Biological",
            "Biological"
      ],
      "IsFDARegulatedDevice": [],
      "IsFDARegulatedDrug": [],
      "IsPPSD": [],
      "IsUSExport": [],
      "IsUnapprovedDevice": [],
      "Keyword": [
            "Hypoxic-Ischemic Encephalopathy",
            "progenitor cell",
            "paracrine factor",
            "adipose mesenchymal stem cell",
            "neonate"
      ],
      "LargeDocDate": [],
      "LargeDocFilename": [],
      "LargeDocHasICF": [],
      "LargeDocHasProtocol": [],
      "LargeDocHasSAP": [],
      "LargeDocLabel": [],
      "LargeDocTypeAbbrev": [],
      "LargeDocUploadDate": [],
      "LastKnownStatus": [
            "Recruiting"
      ],
      "LastUpdatePostDate": [
            "August 3, 2016"
      ],
      "LastUpdatePostDateType": [
            "Estimate"
      ],
      "LastUpdateSubmitDate": [
            "July 30, 2016"
      ],
      "LeadSponsorClass": [
            "OTHER"
      ],
      "LeadSponsorName": [
            "Navy General Hospital, Beijing"
      ],
      "LimitationsAndCaveatsDescription": [],
      "LocationCity": [
            "Beijing",
            "Beijing"
      ],
      "LocationContactEMail": [
            "hjzyyerke@163.com",
            "hjzyyerke@163.com",
            "hjzyynicu@163.com"
      ],
      "LocationContactName": [
            "Zuo Luan, MD",
            "Zuo Luan, MD",
            "Weipeng Liu, MD",
            "Zuo Luan, MD",
            "Weipeng Liu, MD",
            "Zuo Luan, MD",
            "Weipeng Liu, MD"
      ],
      "LocationContactPhone": [
            "18600310270",
            "135581797015"
      ],
      "LocationContactPhoneExt": [],
      "LocationContactRole": [
            "Contact",
            "Principal Investigator",
            "Sub-Investigator",
            "Contact",
            "Contact",
            "Principal Investigator",
            "Sub-Investigator"
      ],
      "LocationCountry": [
            "China",
            "China"
      ],
      "LocationFacility": [
            "Navy General Hospital",
            "Navy General Hospital"
      ],
      "LocationState": [
            "Beijing"
      ],
      "LocationStatus": [
            "Recruiting",
            "Recruiting"
      ],
      "LocationZip": [
            "100048",
            "100048"
      ],
      "MaximumAge": [
            "14 Days"
      ],
      "MinimumAge": [
            "1 Day"
      ],
      "NCTIdAlias": [],
      "OfficialTitle": [
            "Safety and Efficacy Study of Neural Progenitor Cell Transplantation and Paracrine Factors From Human Mesenchymal Stem Cells to Treat Newborn With Hypoxic-ischemic Encephalopathy"
      ],
      "OrgClass": [
            "OTHER"
      ],
      "OrgFullName": [
            "Navy General Hospital, Beijing"
      ],
      "OrgStudyId": [
            "NavyGHB-P-01"
      ],
      "OrgStudyIdDomain": [],
      "OrgStudyIdLink": [],
      "OrgStudyIdType": [],
      "OtherEventAssessmentType": [],
      "OtherEventNotes": [],
      "OtherEventOrganSystem": [],
      "OtherEventSourceVocabulary": [],
      "OtherEventStatsGroupId": [],
      "OtherEventStatsNumAffected": [],
      "OtherEventStatsNumAtRisk": [],
      "OtherEventStatsNumEvents": [],
      "OtherEventTerm": [],
      "OtherOutcomeDescription": [],
      "OtherOutcomeMeasure": [],
      "OtherOutcomeTimeFrame": [],
      "OutcomeAnalysisCILowerLimit": [],
      "OutcomeAnalysisCILowerLimitComment": [],
      "OutcomeAnalysisCINumSides": [],
      "OutcomeAnalysisCIPctValue": [],
      "OutcomeAnalysisCIUpperLimit": [],
      "OutcomeAnalysisCIUpperLimitComment": [],
      "OutcomeAnalysisDispersionType": [],
      "OutcomeAnalysisDispersionValue": [],
      "OutcomeAnalysisEstimateComment": [],
      "OutcomeAnalysisGroupDescription": [],
      "OutcomeAnalysisGroupId": [],
      "OutcomeAnalysisNonInferiorityComment": [],
      "OutcomeAnalysisNonInferiorityType": [],
      "OutcomeAnalysisOtherAnalysisDescription": [],
      "OutcomeAnalysisPValue": [],
      "OutcomeAnalysisPValueComment": [],
      "OutcomeAnalysisParamType": [],
      "OutcomeAnalysisParamValue": [],
      "OutcomeAnalysisStatisticalComment": [],
      "OutcomeAnalysisStatisticalMethod": [],
      "OutcomeAnalysisTestedNonInferiority": [],
      "OutcomeCategoryTitle": [],
      "OutcomeClassDenomCountGroupId": [],
      "OutcomeClassDenomCountValue": [],
      "OutcomeClassDenomUnits": [],
      "OutcomeClassTitle": [],
      "OutcomeDenomCountGroupId": [],
      "OutcomeDenomCountValue": [],
      "OutcomeDenomUnits": [],
      "OutcomeGroupDescription": [],
      "OutcomeGroupId": [],
      "OutcomeGroupTitle": [],
      "OutcomeMeasureAnticipatedPostingDate": [],
      "OutcomeMeasureCalculatePct": [],
      "OutcomeMeasureDenomUnitsSelected": [],
      "OutcomeMeasureDescription": [],
      "OutcomeMeasureDispersionType": [],
      "OutcomeMeasureParamType": [],
      "OutcomeMeasurePopulationDescription": [],
      "OutcomeMeasureReportingStatus": [],
      "OutcomeMeasureTimeFrame": [],
      "OutcomeMeasureTitle": [],
      "OutcomeMeasureType": [],
      "OutcomeMeasureTypeUnitsAnalyzed": [],
      "OutcomeMeasureUnitOfMeasure": [],
      "OutcomeMeasurementComment": [],
      "OutcomeMeasurementGroupId": [],
      "OutcomeMeasurementLowerLimit": [],
      "OutcomeMeasurementSpread": [],
      "OutcomeMeasurementUpperLimit": [],
      "OutcomeMeasurementValue": [],
      "OverallOfficialAffiliation": [
            "Navy General Hosiptal"
      ],
      "OverallOfficialName": [
            "Zuo Luan, MD"
      ],
      "OverallOfficialRole": [
            "Study Chair"
      ],
      "OverallStatus": [
            "Unknown status"
      ],
      "OversightHasDMC": [
            "Yes"
      ],
      "PatientRegistry": [],
      "Phase": [
            "Not Applicable"
      ],
      "PointOfContactEMail": [],
      "PointOfContactOrganization": [],
      "PointOfContactPhone": [],
      "PointOfContactPhoneExt": [],
      "PointOfContactTitle": [],
      "PrimaryCompletionDate": [
            "July 2017"
      ],
      "PrimaryCompletionDateType": [
            "Anticipated"
      ],
      "PrimaryOutcomeDescription": [
            "adverse events like fever\u3001infection\u3001seizures\u3001hemorrhage coursed by interventions"
      ],
      "PrimaryOutcomeMeasure": [
            "Neonatal Behavioral Neurological Assessment",
            "number of adverse events",
            "Neonatal Behavioral Neurological Assessment"
      ],
      "PrimaryOutcomeTimeFrame": [
            "14days after birth",
            "7days after cell or factor injection",
            "28days after birth"
      ],
      "ReferenceCitation": [
            "Luan Z, Liu W, Qu S, Du K, He S, Wang Z, Yang Y, Wang C, Gong X. Effects of neural progenitor cell transplantation in children with severe cerebral palsy. Cell Transplant. 2012;21 Suppl 1:S91-8. doi: 10.3727/096368912X633806.",
            "Bruschettini M, Romantsik O, Moreira A, Ley D, Th\u00e9baud B. Stem cell-based interventions for the prevention of morbidity and mortality following hypoxic-ischaemic encephalopathy in newborn infants. Cochrane Database Syst Rev. 2020 Aug 19;8:CD013202. doi: 10.1002/14651858.CD013202.pub2."
      ],
      "ReferencePMID": [
            "22507684",
            "32813884"
      ],
      "ReferenceType": [
            "background",
            "derived"
      ],
      "RemovedCountry": [],
      "ResponsiblePartyInvestigatorAffiliation": [
            "Navy General Hospital, Beijing"
      ],
      "ResponsiblePartyInvestigatorFullName": [
            "Zuo Luan"
      ],
      "ResponsiblePartyInvestigatorTitle": [
            "Principal Investigator"
      ],
      "ResponsiblePartyOldNameTitle": [],
      "ResponsiblePartyOldOrganization": [],
      "ResponsiblePartyType": [
            "Principal Investigator"
      ],
      "ResultsFirstPostDate": [],
      "ResultsFirstPostDateType": [],
      "ResultsFirstPostedQCCommentsDate": [],
      "ResultsFirstPostedQCCommentsDateType": [],
      "ResultsFirstSubmitDate": [],
      "ResultsFirstSubmitQCDate": [],
      "RetractionPMID": [],
      "RetractionSource": [],
      "SamplingMethod": [],
      "SecondaryId": [],
      "SecondaryIdDomain": [],
      "SecondaryIdLink": [],
      "SecondaryIdType": [],
      "SecondaryOutcomeDescription": [
            "Gross motor function measure assessment for children diagnosed cerebral palsy",
            "Gross motor function measure assessment for children diagnosed cerebral palsy",
            "Gross motor function measure assessment for children diagnosed cerebral palsy",
            "Gross motor function measure assessment for children diagnosed cerebral palsy"
      ],
      "SecondaryOutcomeMeasure": [
            "Bayley score",
            "Bayley score",
            "Peabody development measure scale",
            "Peabody development measure scale",
            "Number of death",
            "Number of participants with treatment-related central nervous tumor as assessed by Magnetic Resonance Imaging or CT"
      ],
      "SecondaryOutcomeTimeFrame": [
            "12 months after birth",
            "18 months after birth",
            "12 months after birth",
            "18 months after birth",
            "1 years after birth",
            "5 years after birth"
      ],
      "SeeAlsoLinkLabel": [],
      "SeeAlsoLinkURL": [],
      "SeriousEventAssessmentType": [],
      "SeriousEventNotes": [],
      "SeriousEventOrganSystem": [],
      "SeriousEventSourceVocabulary": [],
      "SeriousEventStatsGroupId": [],
      "SeriousEventStatsNumAffected": [],
      "SeriousEventStatsNumAtRisk": [],
      "SeriousEventStatsNumEvents": [],
      "SeriousEventTerm": [],
      "StartDate": [
            "January 2013"
      ],
      "StartDateType": [],
      "StatusVerifiedDate": [
            "July 2016"
      ],
      "StdAge": [
            "Child"
      ],
      "StudyFirstPostDate": [
            "August 3, 2016"
      ],
      "StudyFirstPostDateType": [
            "Estimate"
      ],
      "StudyFirstSubmitDate": [
            "April 27, 2014"
      ],
      "StudyFirstSubmitQCDate": [
            "July 30, 2016"
      ],
      "StudyPopulation": [],
      "StudyType": [
            "Interventional"
      ],
      "SubmissionMCPReleaseN": [],
      "SubmissionReleaseDate": [],
      "SubmissionResetDate": [],
      "SubmissionUnreleaseDate": [],
      "TargetDuration": [],
      "UnpostedEventDate": [],
      "UnpostedEventType": [],
      "UnpostedResponsibleParty": [],
      "VersionHolder": [
            "October 10, 2022"
      ],
      "WhyStopped": []
}